DKS
DICK'S Sporting Goods, Inc.
DKS has lower modeled downside risk, despite its lower overall score.
RIVN
Rivian Automotive, Inc.
RIVN has the edge over DKS overall, supported by stronger valuation and stronger fundamentals.
DKS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Under pressure | |
| Healthy |
DKS's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DKS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $84.34 | -42% |
| Forward | 12x | $146 | — |
| Fair | 14x | $124 | -15% |
| Current | 16x | $146 | — |
| Expensive | 18x | $162 | +11% |
Historical ranges are pointers, not guarantees.
DKS's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
DKS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect DKS's earnings to grow and its profitability to improve, with its revenue holding steady.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
RIVN has the edge over DKS on the outlook, with more favorable revenue expectations.
DKS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.44 | +37% |
| Q3 2026 | $9.06 | -37% |
| Q2 2026 | $10.27 | -27% |
| Q1 2026 | $9.97 | -29% |
| Q4 2025 | $12.44 | -11% |
| Q3 2025 | $14.33 | +5.1% |
| Q2 2025 | $13.99 | +16% |
| Q1 2025 | $14.05 | +15% |
| Q4 2024 | $13.99 | +25% |
DKS has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
DKS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.6B | +53% |
| Q2 2026 | $5.2B | +63% |
| Q1 2026 | $6.2B | +60% |
| Q4 2025 | $4.2B | +36% |
| Q3 2025 | $3.6B | +5% |
| Q2 2025 | $3.2B | +5.2% |
| Q1 2025 | $3.9B | +0.5% |
| Q4 2024 | $3.1B | +0.5% |
DKS has the edge over RIVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | -4.5 points |
| Q2 2026 | 8.7% | -2.8 points |
| Q1 2026 | 3% | -7 points |
| Q4 2025 | 2.2% | -7.1 points |
| Q3 2025 | 12% | -1.1 points |
| Q2 2025 | 12% | +0.6 points |
| Q1 2025 | 9.9% | +0.3 points |
| Q4 2024 | 9.4% | +0.4 points |
DKS has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
DKS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $133M | -55% |
| Q2 2026 | -$84.2M | +$2.5M |
| Q1 2026 | $706.2M | +79% |
| Q4 2025 | -$515.6M | -$376.3M |
| Q3 2025 | $296.2M | +65% |
| Q2 2025 | -$86.7M | -217% |
| Q1 2025 | $394.5M | -33% |
| Q4 2024 | -$139.3M | -$49.6M |
DKS has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
DKS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -277K shares |
| 1 year | +11% | +9.1M shares |
| 3 years | +3.9% | +3.3M shares |
| 5 years | -18% | -19.1M shares |
| Available history | +4.1% | +3.5M shares |
DKS has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $141.2M |
| Q1 2026 | $43.5M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $303.7M |
| Q1 2025 | $92.8M |
| Q4 2024 | $6.7M |
DKS spent $185M buying back its own shares over the past year, down 54% from the year before.
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
DKS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.0x | Very low |
DKS's net debt is less than a year of its operating earnings (EBITDA).
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DKS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.2 | Neutral |
| Stochastic | 24.3 | Neutral |
DKS's weekly RSI is 38 (neutral) and its Stochastic is 24 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
DKS PE vs Consumer Cyclical Sector
| Metric | DKS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 71 | 47 | 24 pts above |
DKS is trading at 16x earnings, a 11% discount to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
DKS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $141.1 | 3.3% above |
| 20 week MA | $166.3 | 12% below |
| 50 week MA | $194.2 | 25% below |
| 100 week MA | $202.5 | 28% below |
| 200 week MA | $184.0 | 21% below |
DKS has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
DKS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $55.6 | +15% |
| 2021 | $55.6 | $103.9 | +87% |
| 2022 | $103.9 | $111.1 | +6.9% |
| 2023 | $111.1 | $147.0 | +32% |
| 2024 | $147.0 | $234.1 | +59% |
| 2025 | $234.1 | $210.3 | -10% |
| 2026 YTD | $210.3 | $145.7 | -31% |
DKS has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.